254 related articles for article (PubMed ID: 22698489)
1. Nonfasting glucose, ischemic heart disease, and myocardial infarction: a Mendelian randomization study.
Benn M; Tybjaerg-Hansen A; McCarthy MI; Jensen GB; Grande P; Nordestgaard BG
J Am Coll Cardiol; 2012 Jun; 59(25):2356-65. PubMed ID: 22698489
[TBL] [Abstract][Full Text] [Related]
2. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.
Nordestgaard BG; Benn M; Schnohr P; Tybjaerg-Hansen A
JAMA; 2007 Jul; 298(3):299-308. PubMed ID: 17635890
[TBL] [Abstract][Full Text] [Related]
3. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.
Varbo A; Benn M; Tybjærg-Hansen A; Nordestgaard BG
Circulation; 2013 Sep; 128(12):1298-309. PubMed ID: 23926208
[TBL] [Abstract][Full Text] [Related]
4. Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis.
Stender S; Frikke-Schmidt R; Nordestgaard BG; Grande P; Tybjaerg-Hansen A
J Intern Med; 2013 Jan; 273(1):59-68. PubMed ID: 22805420
[TBL] [Abstract][Full Text] [Related]
5. Remnant cholesterol as a causal risk factor for ischemic heart disease.
Varbo A; Benn M; Tybjærg-Hansen A; Jørgensen AB; Frikke-Schmidt R; Nordestgaard BG
J Am Coll Cardiol; 2013 Jan; 61(4):427-436. PubMed ID: 23265341
[TBL] [Abstract][Full Text] [Related]
6. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.
Frikke-Schmidt R; Nordestgaard BG; Stene MC; Sethi AA; Remaley AT; Schnohr P; Grande P; Tybjaerg-Hansen A
JAMA; 2008 Jun; 299(21):2524-32. PubMed ID: 18523221
[TBL] [Abstract][Full Text] [Related]
7. Milk intake is not associated with ischaemic heart disease in observational or Mendelian randomization analyses in 98,529 Danish adults.
Bergholdt HK; Nordestgaard BG; Varbo A; Ellervik C
Int J Epidemiol; 2015 Apr; 44(2):587-603. PubMed ID: 26085675
[TBL] [Abstract][Full Text] [Related]
8. TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.
Varbo A; Benn M; Tybjærg-Hansen A; Grande P; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):451-7. PubMed ID: 21071687
[TBL] [Abstract][Full Text] [Related]
9. LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals.
Haase CL; Tybjærg-Hansen A; Qayyum AA; Schou J; Nordestgaard BG; Frikke-Schmidt R
J Clin Endocrinol Metab; 2012 Feb; 97(2):E248-56. PubMed ID: 22090275
[TBL] [Abstract][Full Text] [Related]
10. Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population.
Varbo A; Freiberg JJ; Nordestgaard BG
Clin Chem; 2015 Mar; 61(3):533-43. PubMed ID: 25605681
[TBL] [Abstract][Full Text] [Related]
11. The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach.
Nordestgaard BG; Palmer TM; Benn M; Zacho J; Tybjaerg-Hansen A; Davey Smith G; Timpson NJ
PLoS Med; 2012; 9(5):e1001212. PubMed ID: 22563304
[TBL] [Abstract][Full Text] [Related]
12. No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study.
Brøndum-Jacobsen P; Benn M; Afzal S; Nordestgaard BG
Int J Epidemiol; 2015 Apr; 44(2):651-61. PubMed ID: 25981321
[TBL] [Abstract][Full Text] [Related]
13. Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up.
Langsted A; Freiberg JJ; Tybjaerg-Hansen A; Schnohr P; Jensen GB; Nordestgaard BG
J Intern Med; 2011 Jul; 270(1):65-75. PubMed ID: 21198993
[TBL] [Abstract][Full Text] [Related]
14. PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses.
Benn M; Nordestgaard BG; Grande P; Schnohr P; Tybjaerg-Hansen A
J Am Coll Cardiol; 2010 Jun; 55(25):2833-42. PubMed ID: 20579540
[TBL] [Abstract][Full Text] [Related]
15. Remnant cholesterol, low-density lipoprotein cholesterol, and blood pressure as mediators from obesity to ischemic heart disease.
Varbo A; Benn M; Smith GD; Timpson NJ; Tybjaerg-Hansen A; Nordestgaard BG
Circ Res; 2015 Feb; 116(4):665-73. PubMed ID: 25411050
[TBL] [Abstract][Full Text] [Related]
16. Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study.
Wittrup HH; Andersen RV; Tybjaerg-Hansen A; Jensen GB; Nordestgaard BG
J Clin Endocrinol Metab; 2006 Apr; 91(4):1438-45. PubMed ID: 16418216
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population.
Rasmussen KL; Tybjærg-Hansen A; Nordestgaard BG; Frikke-Schmidt R
Atherosclerosis; 2016 Mar; 246():63-70. PubMed ID: 26761769
[TBL] [Abstract][Full Text] [Related]
18. Pentanucleotide repeat polymorphism, lipoprotein(a) levels, and risk of ischemic heart disease.
Kamstrup PR; Tybjaerg-Hansen A; Steffensen R; Nordestgaard BG
J Clin Endocrinol Metab; 2008 Oct; 93(10):3769-76. PubMed ID: 18682504
[TBL] [Abstract][Full Text] [Related]
19. Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study.
Thomsen M; Varbo A; Tybjærg-Hansen A; Nordestgaard BG
Clin Chem; 2014 May; 60(5):737-46. PubMed ID: 24436475
[TBL] [Abstract][Full Text] [Related]
20. Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome.
Thomsen M; Nordestgaard BG
JAMA Intern Med; 2014 Jan; 174(1):15-22. PubMed ID: 24217719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]